578 related articles for article (PubMed ID: 20675008)
1. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.
Gupta A; Dhiman RK; Kumari S; Rana S; Agarwal R; Duseja A; Chawla Y
J Hepatol; 2010 Nov; 53(5):849-55. PubMed ID: 20675008
[TBL] [Abstract][Full Text] [Related]
2. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy.
Lunia MK; Sharma BC; Sachdeva S
Hepatol Int; 2013 Mar; 7(1):268-73. PubMed ID: 26201641
[TBL] [Abstract][Full Text] [Related]
3. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
4. [Bacterial overgrowth in small intestine in patients with liver cirrhosis].
Chesta J; Silva M; Thompson L; del Canto E; Defilippi C
Rev Med Chil; 1991 Jun; 119(6):626-32. PubMed ID: 1844365
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
[TBL] [Abstract][Full Text] [Related]
6. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
7. Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients.
Resmini E; Parodi A; Savarino V; Greco A; Rebora A; Minuto F; Ferone D
J Clin Endocrinol Metab; 2007 Jun; 92(6):2119-24. PubMed ID: 17405840
[TBL] [Abstract][Full Text] [Related]
8. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
9. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India.
Rana S; Bhansali A; Bhadada S; Sharma S; Kaur J; Singh K
Diabetes Technol Ther; 2011 Nov; 13(11):1115-20. PubMed ID: 21770765
[TBL] [Abstract][Full Text] [Related]
10. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
[TBL] [Abstract][Full Text] [Related]
11. Prolonged orocecal transit time enhances serum bile acids through bacterial overgrowth, contributing factor to gallstone disease.
Kaur J; Rana SV; Gupta R; Gupta V; Sharma SK; Dhawan DK
J Clin Gastroenterol; 2014 Apr; 48(4):365-9. PubMed ID: 24598592
[TBL] [Abstract][Full Text] [Related]
12. Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes.
Abid S; Kamran M; Abid A; Butt N; Awan S; Abbas Z
Sci Rep; 2020 Jun; 10(1):10079. PubMed ID: 32572109
[TBL] [Abstract][Full Text] [Related]
13. Liver damage in human small intestinal bacterial overgrowth.
Riordan SM; McIver CJ; Williams R
Am J Gastroenterol; 1998 Feb; 93(2):234-7. PubMed ID: 9468250
[TBL] [Abstract][Full Text] [Related]
14. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
[TBL] [Abstract][Full Text] [Related]
15. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
16. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
[TBL] [Abstract][Full Text] [Related]
17. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.
Pande C; Kumar A; Sarin SK
Aliment Pharmacol Ther; 2009 Jun; 29(12):1273-81. PubMed ID: 19302262
[TBL] [Abstract][Full Text] [Related]
18. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
19. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
